E. Samantas

2.6k total citations
68 papers, 1.9k citations indexed

About

E. Samantas is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, E. Samantas has authored 68 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Oncology, 27 papers in Pulmonary and Respiratory Medicine and 14 papers in Epidemiology. Recurrent topics in E. Samantas's work include Lung Cancer Treatments and Mutations (18 papers), Lung Cancer Research Studies (17 papers) and Cancer Treatment and Pharmacology (14 papers). E. Samantas is often cited by papers focused on Lung Cancer Treatments and Mutations (18 papers), Lung Cancer Research Studies (17 papers) and Cancer Treatment and Pharmacology (14 papers). E. Samantas collaborates with scholars based in Greece, Germany and United States. E. Samantas's co-authors include George Fountzilas, Dimosthenis Skarlos, P. Kosmidis, Nicholas Pavlidis, Haralabos P. Kalofonos, Dimitrios Bafaloukos, Dimitrios Pectasides, Pavlos Papakostas, Evangelos Briasoulis and Christos Christodoulou and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Annals of Oncology.

In The Last Decade

E. Samantas

65 papers receiving 1.9k citations

Peers

Countries citing papers authored by E. Samantas

Since Specialization

Citations

This map shows the geographic impact of E. Samantas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Samantas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Samantas more than expected).

Fields of papers citing papers by E. Samantas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Samantas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Samantas. The network helps show where E. Samantas may publish in the future.

Co-authorship network of co-authors of E. Samantas

This figure shows the co-authorship network connecting the top 25 collaborators of E. Samantas. A scholar is included among the top collaborators of E. Samantas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Samantas. E. Samantas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Genetic testing in patients with pancreatic cancer to reveal pathogenic variants in cancer susceptibility genes. 2023 ·Journal of Clinical Oncology ·(unknown), (unknown), Κωνσταντίνος Αγιαννιτόπουλος, Georgios Tsaousis, Mustafa Özdoğan, Bülent Karabulut, (unknown), Dimitrios C. Ziogas, (unknown), Christos Christodoulou, E. Samantas, (unknown), Ilias Athanasiadis, Αngelos Koutras, Eirini Papadopoulou, George Nasioulas	1
2	A Real-World, Observational, Prospective Study to Assess the Molecular Epidemiology of Epidermal Growth Factor Receptor (EGFR) Mutations upon Progression on or after First-Line Therapy with a First- or Second-Generation EGFR Tyrosine Kinase Inhibitor in EGFR Mutation-Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer: The ‘LUNGFUL’ Study 2021 ·Cancers ·Giannis Mountzios, Anna Koumarianou, (unknown), Dimitriοs Mavroudis, E. Samantas, (unknown), Helena Linardou, (unknown), (unknown), Michalis V. Karamouzis, George Pentheroudakis, Sofia Lampaki, Μarios E. Froudarakis, (unknown), (unknown), (unknown), (unknown), (unknown), Konstantinos N. Syrigos	5
3	Genotyping KRAS and EGFR Mutations in Greek Patients With Non-small-cell Lung Cancer: Incidence, Significance and Implications for Treatment 2019 ·Cancer Genomics & Proteomics ·Helena Linardou, (unknown), G. Kouvatseas, Giannis Mountzios, Vasilios Karavasilis, E. Samantas, Anna Kalogera‐Fountzila, Despina Televantou, Kyriaki Papadopoulou, (unknown), (unknown), Thomas Zaramboukas, Ioannis Efstratiou, Sofia Lampaki, (unknown), (unknown), Konstantinos N. Syrigos, P. Kosmidis, Dimitrios Pectasides, George Fountzilas	11
4	Effective use of levosimendan in anthracycline-induced cardiomyopathy: A case report 2017 ·Heart & Lung ·(unknown), (unknown), Joseph Sgouros, (unknown), (unknown), George Stamoulis, (unknown), (unknown), E. Samantas	4
5	Prognostic Significance of VEGFC and VEGFR1 mRNA Expression According to HER2 Status in Breast Cancer: A Study of Primary Tumors from Patients with High-risk Early Breast Cancer Participating in a Randomized Hellenic Cooperative Oncology Group Trial. 2015 ·PubMed ·Helena Linardou, Konstantine T. Kalogeras, Ralf Kronenwett, Zoi Alexopoulou, Ralph M. Wirtz, Flora Zagouri, Chrisoula D. Scopa, Helen Gogas, Kalliopi Petraki, Christos Christodoulou, Kitty Pavlakis, Αngelos Koutras, E. Samantas, (unknown), Dimitrios Pectasides, Dimitrios Bafaloukos, George Fountzilas	6
6	Prognostic significance of RACGAP1 mRNA expression in high-risk early breast cancer: a study in primary tumors of breast cancer patients participating in a randomized Hellenic Cooperative Oncology Group trial 2012 ·Cancer Chemotherapy and Pharmacology ·Kyriaki Pliarchopoulou, Konstantine T. Kalogeras, Ralf Kronenwett, Ralph M. Wirtz, Anastasia G Eleftheraki, Anna Batistatou, Mattheos Bobos, (unknown), Genovefa Polychronidou, Helen Gogas, E. Samantas, Christos Christodoulou, Thomas Makatsoris, Nicholas Pavlidis, Dimitrios Pectasides, George Fountzilas	47
7	Paclitaxel and gemcitabine versus paclitaxel and vinorelbine in patients with advanced non-small-cell lung cancer. A phase III study of the Hellenic Cooperative Oncology Group (HeCOG) 2010 ·Annals of Oncology ·P. Kosmidis, George Fountzilas, Anastasia G Eleftheraki, Haralabos P. Kalofonos, George Pentheroudakis, Dimosthenis Skarlos, Meletios Α. Dimopoulos, Dimitrios Bafaloukos, Dimitrios Pectasides, E. Samantas, J. Boukovinas, (unknown), (unknown), (unknown), Konstantinos N. Syrigos	12
8	Pegfilgrastim Administered on the Same Day with Dose-Dense Adjuvant Chemotherapy for Breast Cancer Is Associated with a Higher Incidence of Febrile Neutropenia as Compared to Conventional Growth Factor Support: Matched Case-Control Study of the Hellenic Cooperative Oncology Group 2009 ·Oncology ·Dimosthenis Skarlos, Eleni Timotheadou, Eleni Galani, E. Samantas, Irene Grimani, Evangelos Lianos, Gerasimos Aravantinos, Ioannis Xanthakis, George Pentheroudakis, Dimitrios Pectasides, George Fountzilas	25
9	Carboplatin and Paclitaxel versus Cisplatin, Paclitaxel and Doxorubicin for first-line chemotherapy of Advanced Ovarian Cancer: A Hellenic Cooperative Oncology Group (HeCOG) study 2008 ·European Journal of Cancer ·Gerasimos Aravantinos, George Fountzilas, Aristotelis Bamias, Irene Grimani, (unknown), Haralabos P. Kalofonos, Dimosthenis Skarlos, Theofanis Economopoulos, P. Kosmidis, George P. Stathopoulos, Evangelos Briasoulis, Dimitrios Pectasides, E. Samantas, Eleni Timotheadou, Christos Papadimitriou, Αλέξανδρος Παπανικολάου, (unknown), Pavlos Papakostas, Dimitrios Bafaloukos, Meletios Α. Dimopoulos	13
10	HLA Class II Alleles and the Presence of Circulating Epstein-Barr Virus DNA in Greek Patients with Nasopharyngeal Carcinoma 2008 ·Strahlentherapie und Onkologie ·Charisios Karanikiotis, (unknown), (unknown), (unknown), Theofanis Economopoulos, Samuel Murray, Demetris Papamichael, E. Samantas, (unknown), Lemonia Skoura, Nikolaos Tselis, Nikolaos Zamboglou, George Fountzilas	8
11	Multicenter phase-II trial of irinotecan plus oxaliplatin [IROX regimen] in patients with poor-prognosis cancer of unknown primary: a hellenic cooperative oncology group study 2007 ·Cancer Chemotherapy and Pharmacology ·Evangelos Briasoulis, George Fountzilas, Aristotelis Bamias, Meletios Α. Dimopoulos, (unknown), Gerasimos Aravantinos, E. Samantas, Haralabos P. Kalofonos, Thomas Makatsoris, N. Mylonakis, Pavlos Papakostas, Dimosthenis Skarlos, Ioannis Varthalitis, Nicholas Pavlidis	20
12	Two Cycles of Etoposide/Cisplatin Cured All Patients with Stage I Testicular Seminoma: Risk-Adapted Protocol of the Hellenic Cooperative Oncology Group 2007 ·Urology ·Aristotelis Bamias, Gerasimos Aravantinos, Charalambos Deliveliotis, A. Thanos, G. Klouvas, Nikolaos Antoniou, (unknown), Thomas Makatsoris, E. Samantas, Meletios Α. Dimopoulos	2
13	Non-small cell lung cancer in the young: a retrospective analysis of diagnosis, management and outcome data. 2006 ·PubMed ·Davide Mauri, George Pentheroudakis, D. Bafaloukos, Dimitrios Pectasides, E. Samantas, (unknown), Haralabos P. Kalofonos, K. Syrigos, G. Klouvas, Pavlos Papakostas, P. Kosmidis, George Fountzilas, Nicholas Pavlidis	43
14	Chemotherapy for patients with two favourable subsets of unknown primary carcinoma: Active, but how effective? 2005 ·Acta Oncologica ·George Pentheroudakis, Evangelos Briasoulis, (unknown), George Fountzilas, (unknown), (unknown), E. Samantas, Nicholas Pavlidis	24
15	Paclitaxel, Cisplatin, Leucovorin, and Continuous Infusion Fluorouracil Followed by Concomitant Chemoradiotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck: A Hellenic Cooperative Oncology Group Phase II Study 2005 ·Medical Oncology ·George Fountzilas, (unknown), Anna Kalogera‐Fountzila, Despina Misailidou, (unknown), Maria Karina, Angelos Nikolaou, E. Samantas, Thomas Makatsoris, (unknown), Dimosthenis Skarlos, Aristotelis Bamias, (unknown), Theofanis Economopoulos, (unknown), Nicholas Pavlidis, (unknown)	7
16	Adjuvant Cytotoxic and Endocrine Therapy in Pre- and Postmenopausal Patients With Breast Cancer and One to Nine Infiltrated Nodes 2004 ·American Journal of Clinical Oncology ·George Fountzilas, George P. Stathopoulos, George Kouvatseas, (unknown), G. Klouvas, E. Samantas, (unknown), (unknown), (unknown), (unknown), (unknown), Haralabos P. Kalofonos, Dimitrios Bafaloukos, V. Georgoulias, Evangelia Razis, (unknown), (unknown), P. Kosmidis, Dimosthenis Skarlos, Nicholas Pavlidis	1
17	Pegylated liposomal doxorubicin hydrochloride (PLD) and paclitaxel in recurrent or metastatic head and neck carcinoma: a phase I/II study conducted by the Hellenic Cooperative Oncology Group (HeCOG) 2004 ·Anti-Cancer Drugs ·Jim Janinis, George P. Stathopoulos, Paul Nikolaidis, Haralabos P. Kalofonos, Anna Kalogera‐Fountzila, E. Samantas, Gerasimos Aravantinos, (unknown), (unknown), Thomas Makatsoris, S. Rigatos, Dimitrios Bafaloukos, Meletios Α. Dimopoulos, (unknown), George Fountzilas	6
18	Randomized comparison of early versus late hyperfractionated thoracic irradiation concurrently with chemotherapy in limited disease small-cell lung cancer: A randomized phase II study of the Hellenic Cooperative Oncology Group (HeCOG) 2001 ·Annals of Oncology ·Dimosthenis Skarlos, E. Samantas, Evangelos Briassoulis, (unknown), Nicholas Pavlidis, Haralabos P. Kalofonos, D. Kardamakis, (unknown), P. Kosmidis, D. Tsavdaridis, (unknown), P. Tsekeris, G. Kouvatseas, (unknown), George Fountzilas	85
19	Bcl2 and p53 protein expression in metastatic carcinoma of unknown primary origin: biological and clinical implications. A Hellenic Co-operative Oncology Group study. 1998 ·PubMed ·Evangelos Briasoulis, Maria Tsokos, George Fountzilas, D. Bafaloukos, (unknown), E. Samantas, (unknown), C. Nicolaides, Nicholas Pavlidis	44
20	Randomized comparison of etoposide-cisplatin vs. etoposide-carboplatin and irradiation in small-cell lung cancer 1994 ·Annals of Oncology ·D. Skarlos, E. Samantas, P. Kosmidis, George Fountzilas, (unknown), Ph. Palamidas, N. Mylonakis, (unknown), E. Papadakis, G. Klouvas, D. Theocharis, (unknown), Ekaterini Boleti, (unknown), Nicholas Pavlidis	195

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact